NYSE:MCD
NYSE:MCDHospitality

McDonald's (MCD) Declares US$1.77 Quarterly Dividend Payable September 2025

On July 22, 2025, McDonald's (MCD) reaffirmed its quarterly dividend of $1.77 per share, reinforcing its dedication to shareholder value, with the payment scheduled for mid-September. Meanwhile, the S&P 500 hit new highs amidst trade deal optimism, buoying broader market sentiment and echoing the upward trend with a 1.3% rise over the past week. Amid this favorable backdrop, McDonald's saw its share price climb by 4.07% over the last month, aligning with bullish market conditions, suggesting...
NYSE:BDX
NYSE:BDXMedical Equipment

Becton Dickinson (BDX) Unveils Wearable Injector Trial and Declares US$1.04 Quarterly Dividend

Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership changes. These developments coincided with the company's stock increasing 8% over the past month, aligning with the S&P 500's upward trend. The recent trial highlights BDX's focus on innovation in high-demand biologics, potentially enhancing market confidence. Similarly, the dividend declaration may...
NYSE:T
NYSE:TTelecom

AT&T (T) Reports US$61 Billion Six-Month Revenue, Completes US$1,300 Million Buyback

AT&T (T) posted a modest 1.48% price increase last week amid its announcement of impressive earnings growth and the completion of a significant share buyback program. The company's Q2 results highlighted a strong revenue increase to $30,847 million with net income rising to $4,500 million, contributing positively to overall shareholder returns. Despite these developments, AT&T's performance moved broadly in line with the overall market, which also saw an upswing due to optimistic sentiment...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex Pharmaceuticals (VRTX) Advances Cystic Fibrosis Treatment With ALYFTREK Approval in Canada

Vertex Pharmaceuticals (VRTX) received a significant boost as Health Canada's approval of ALYFTREK marked a vital step in expanding cystic fibrosis treatment options. This approval and other successes, including a reimbursement agreement with NHS England, potentially added positive sentiment to the stock, which saw a 7% rise over the past month. Amidst a generally rising market marked by all-time highs in broader indices like the S&P 500, Vertex's price movement aligns with broader positive...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Intuitive Surgical (ISRG) Reports Strong Q2 Earnings With Revenue Up To US$2,440 Million

Intuitive Surgical (ISRG) recently showcased strong performance in its second-quarter earnings report, with revenue growing significantly to USD 2,440 million and net income increasing to USD 658 million. The 4.73% rise in the company's share price over the last quarter aligns with the broader market trend, supported by optimism surrounding corporate earnings. Additionally, the announcement of David J. Rosa as CEO and advancements in product capabilities might have added to the positive...
NYSE:SEMR
NYSE:SEMRSoftware

High Growth Tech Stocks In US To Watch July 2025

As the S&P 500 reaches new highs amid optimism over trade deals and corporate earnings, investors are closely watching the tech sector, which continues to drive market momentum despite concerns about tariffs and inflation. In this environment, identifying high growth tech stocks involves looking for companies with strong fundamentals and innovative capabilities that can capitalize on current economic conditions.
NYSE:EL
NYSE:ELPersonal Products

3 Stocks Possibly Trading At Discounts Of Up To 46.4%

As the S&P 500 hits new highs amid optimism over trade deals and anticipated earnings reports, investors are keenly observing market movements to identify potential opportunities. In this environment of heightened activity, discerning undervalued stocks can be a strategic approach to potentially capitalize on market fluctuations.
NasdaqGS:CCB
NasdaqGS:CCBBanks

Top Growth Companies With Insider Stake In July 2025

As the S&P 500 reaches new heights amid optimism surrounding trade deals and corporate earnings, investors are keeping a close eye on growth companies with substantial insider ownership. In this environment of record-breaking indices, stocks with high insider stakes can be particularly appealing due to their potential alignment of interests between company executives and shareholders.
NasdaqCM:SAVA
NasdaqCM:SAVAPharmaceuticals

Origin Materials And 2 Additional Promising Penny Stocks

The U.S. stock market has been riding a wave of optimism, with the S&P 500 recently hitting new highs amid positive trade deal developments and anticipation of earnings reports from major companies. In such a buoyant market, investors often look beyond the large-cap stocks to explore opportunities in smaller segments like penny stocks. While "penny stocks" might seem like an outdated term, they still represent a vibrant area for investment, offering potential growth at lower price points when...
NasdaqGS:TRST
NasdaqGS:TRSTBanks

Undiscovered Gems in the US Market for July 2025

As the S&P 500 reaches new heights fueled by trade deal optimism and strong corporate earnings, investors are closely watching how these broader market dynamics will impact small-cap companies. Amid this backdrop of robust economic indicators, identifying undiscovered gems in the U.S. market requires a keen eye for stocks with solid fundamentals and potential for growth that may not yet be reflected in their current valuations.
NasdaqCM:CZFS
NasdaqCM:CZFSBanks

3 Reliable Dividend Stocks Yielding Over 3.1%

The U.S. stock market has been buoyed by optimism around trade deals and corporate earnings, with the S&P 500 reaching new highs despite ongoing tariff concerns. In such a dynamic environment, dividend stocks yielding over 3.1% can offer investors a measure of stability and income, making them an attractive option for those seeking reliable returns amidst market fluctuations.